Risk assessment of consumption of methylchavicol and tarragon: The genotoxic potential in vivo and in vitro

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 696, Issue 1, 2010, Pages 1-9

  Nesslany, Fabrice ^a,b   Parent Massin, Dominique ^c   Marzin, Daniel ^a,b  

^a UNIV LILLE   (France)

^b IPL   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Estragole; Genotoxic; Methylchavicol; Risk assessment; Tarragon

Indexed keywords

ESTRAGOLE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTEMISIA; ARTEMISIA DRACUNCULUS; ARTICLE; CARCINOGENICITY; CHILD; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DNA REPAIR; FEMALE; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MUTAGENICITY; NONHUMAN; PLANT LEAF; PRESCHOOL CHILD; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SCHOOL CHILD;

ANIMALS; ANISOLES; ARTEMISIA; DNA DAMAGE; FEMALE; FLAVORING AGENTS; MALE; MUTAGENICITY TESTS; MUTAGENS; PLANT LEAVES; RATS; RATS, INBRED F344; RISK ASSESSMENT;

ARTEMISIA DRACUNCULUS; RATTUS;

EID: 75049083682     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.11.003     Document Type: Article

References (28)

1. Drinkwater N.R., Miller E.C., Miller N.R., and Pitot H.C. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′hydroxyestragole in the mouse and mutagenicity of 1′-acetoxyestragole in bacteria. J. Natl. Cancer Inst. 57 (1976) 1323-1330
2. Miller E.C., Swanson A.B., Philips D.H., Fletcher T.L., Liem A., and Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 43 (1983) 1124-1134
3. Sekizawa J., and Shibamoto T. Genotoxicity of safrole-related chemicals in microbial test systems. Mutat. Res. 101 (1982) 127-140
4. Zeiger E., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., and Anderson B. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236 (1987) 933-941
5. Jeurissen S.M., Punt A., Delatour T., and Rietjens I.M. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1′-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. Food Chem. Toxicol. 46 (2008) 2296-2302
6. Swanson A.B., Chambliss D.D., Blomquist J.C., Miller E.C., and Miller J.A. Mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants. Mutat. Res. 60 (1979) 143-153
7. Müller L.P., Kasper K., Muller-Tegethoff K., and Petr T. The genotoxic potential in vitro and in vivo of the allyl benzene etheric oils estragole, basil oil and trans anethole. Mutat. Res. 325 (1994) 129-136
8. Howes A.J., Chan V.S.W., and Caldwell J. Structure-specificity of the genotoxicity of some naturally occurring alkylbenzenes determined by the unscheduled DNA synthesis in rat hepatocytes. Food Cosmet. Toxicol. 28 (1990) 537-542
9. Chan V.S., and Caldwell J. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites. Food Chem. Toxicol. 30 (1992) 831-836
10. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 5 (1984) 1613-1622
11. Wiseman R.W., Miller E.C., Müller J.A., and Liem A. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 47 (1987) 2275-2283
12. OECD genetic toxicology: DNA damage and repair/unscheduled DNA synthesis in mammalian cells in vitro, OECD guideline 482, 23 October 1986.
13. OECD guideline for the testing of chemicals: unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo, OECD guideline 486, 21st July 1997.
14. OECD guideline for the testing of chemicals: mammalian erythrocyte micronucleus test, OECD guideline 474, 21st July 1997.
15. Miller J.A., and Miller E.C. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. Br. J. Cancer 48 (1983) 1-15
16. Fennell T.R., Wiseman R.W., Miller J.A., and Miller E.C. Major role of hepatic sulfotransferase activity in the metabolic activation. DNA adduct formation, and carcinogenicity of 1′-hydroxy-2′,3′-dehydroestragole in infant male C57BL/6J × C3H/HeJ F1 mice. Cancer Res. 45 (1985) 5310-5320
17. Guenthner T.M., and Luo G. Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Toxicology 160 (2001) 47-58
18. Luo G., Qato M.K., and Guenthner T.M. Hydrolysis of the 2′,3′-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases. Drug Metab. Dispos. 20 (1992) 440-445
19. Luo G., and Guenthner T.M. Metabolism of allylbenzene 2′,3′-oxide and estragole 2′,3′-oxide in the isolated perfused rat liver. J. Pharmacol. Exp. Ther. 272 (1995) 588-596
20. Luo G., and Guenthner T.M. Covalent binding to DNA in vitro of 2′,3′-oxides derived from allylbenzene analogs. Drug Metab. Dispos. 24 (1996) 1020-1027
21. Lyer L.V., Ho M.N., Shinn W.M., Bradford W.W., Tanga M.J., Nath S.S., and Green C.E. Glucuronidation of 1′-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9. Toxicol. Sci. 73 (2003) 36-43
22. Sangster S.A., Caldwell J., Hutt A.J., Anthony A., and Smith R.L. The metabolic disposition of [methoxy-14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers. Xenobiotica 17 (1987) 1223-1232
23. Anthony A., Caldwell J., Hutt A.J., and Smith R.L. Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole. Food Chem. Toxicol. (1987) 25799-25806
24. Punt A., Paini A., Boersma M.G., Freidig A.P., Delatour T., Scholz G., Schilter B., van Bladeren P.J., and Rietjens I.M.C.M. Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats. Toxicol. Sci. 110 (2009) 255-269
25. Punt A., Freidig A.P., Delatour T., Scholz G., Boersma M.G., Schilter B., Van Bladeren P.J., and Rietjens I.M.C.M. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat. Toxicol. Appl. Pharmacol. 231 (2008) 248-259
26. Waddell W.J. Thresholds of carcinogenicity of flavors. Toxicol. Sci. 68 (2002) 275-279
27. Waddell W.J. Thresholds of carcinogenicity in the ED01 study. Toxicol. Sci. 72 (2003) 158-163
28. Smith R.L., Adams T.B., Doull J., Feron V.J., Goodman J.I., Marnett L.J., Portoghese P.S., Waddell W.J., Wagner B.M., Rogers A.E., Caldwell J., and Sipes I.G. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances-methyl eugenol and estragole. Food Chem. Toxicol. 40 (2002) 851-870